BOW
Bowhead Specialty Holdings Inc.
BOW's fundamentals are mixed: revenue grew 24%, but its operating margin fell 1 points to 12%. At 19x earnings, it's trading in line with its usual 18x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BOW Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BOW's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BOW.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BOW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 15x | $34.03 | — |
| Cheap | 16x | $28.41 | -17% |
| Fair | 18x | $32.73 | -3.8% |
| Current | 19x | $34.03 | — |
| Expensive | 34x | $60.90 | +79% |
Historical ranges are pointers, not guarantees.
BOW's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 15x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BOW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BOW, with profitability holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BOW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +29% |
| Q3 2026 | $1.78 | +14% |
| Q2 2026 | $1.85 | +26% |
| Q1 2026 | $1.73 | +32% |
| Q4 2025 | $1.59 | +34% |
| Q3 2025 | $1.56 | +68% |
| Q2 2025 | $1.47 | +73% |
| Q1 2025 | $1.31 | +52% |
| Q4 2024 | $1.19 | +49% |
BOW has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BOW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $171.8M | +19% |
| Q2 2026 | $163.9M | +23% |
| Q1 2026 | $155.7M | +27% |
| Q4 2025 | $151.7M | +27% |
| Q3 2025 | $143.9M | +23% |
| Q2 2025 | $133.3M | +35% |
| Q1 2025 | $122.7M | +35% |
| Q4 2024 | $119.3M | +44% |
BOW's revenue has grown year over year every quarter since early 2024: $172M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.3% | -4 points |
| Q2 2026 | 13% | +0.7 points |
| Q1 2026 | 13% | +1.4 points |
| Q4 2025 | 12% | -3.5 points |
| Q3 2025 | 13% | -0.3 points |
| Q2 2025 | 12% | +4.4 points |
| Q1 2025 | 12% | +1.8 points |
| Q4 2024 | 15% | +8.3 points |
BOW has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
BOW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $191.3M | +69% |
| Q2 2026 | $92.5M | -14% |
| Q1 2026 | $64.2M | +38% |
| Q4 2025 | $58.6M | -3.7% |
| Q3 2025 | $113.5M | -4.2% |
| Q1 2025 | $46.5M | +13% |
| Q4 2024 | $60.9M | +0.8% |
| Q3 2024 | $118.4M | +36% |
BOW has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BOW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.1% | +699K shares |
| 1 year | +1.8% | +606K shares |
| 3 years | +8.6% | +2.7M shares |
BOW has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BOW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -2.8x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2024 | -2.0x | Net Cash |
| Q4 2023 | -3.4x | Net Cash |
BOW has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BOW.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BOW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.2 | Neutral |
| Stochastic | 56.5 | Neutral |
BOW's weekly RSI is 69 (neutral) and its Stochastic is 57 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BOW PE vs Financial Services Sector
| Metric | BOW | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 47% above |
| PE % | 55 | 27 | 28 pts above |
BOW is trading at 19x earnings, a 47% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
BOW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.0 | 0.1% above |
| 20 week MA | $33.1 | 2.7% above |
| 50 week MA | $28.5 | 19% above |
| 100 week MA | $30.8 | 11% above |
BOW has stronger trend alignment. BOW is above 4 of 4 weekly averages versus IREN above 1 of 5.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BOW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $25.7 | $34.5 | +34% |
| 2025 | $34.5 | $28.5 | -17% |
| 2026 YTD | $28.5 | $34.0 | +19% |
BOW has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.